| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.0076 | 0.8 |
| mRNA | sotrastaurin | CTRPv2 | pan-cancer | AAC | 0.0096 | 0.8 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.0078 | 0.8 |
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | Bryostatin 1 | GDSC1000 | pan-cancer | AAC | 0.0082 | 0.8 |
| mRNA | UNC0638 | GDSC1000 | pan-cancer | AAC | 0.0068 | 0.8 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | -0.0072 | 0.8 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | -0.0089 | 0.8 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0077 | 0.8 |